Literature DB >> 18657804

The LIM protein LIMD1 influences osteoblast differentiation and function.

Hilary F Luderer1, Shuting Bai, Gregory D Longmore.   

Abstract

The balance between bone resorption and bone formation involves the coordinated activities of osteoblasts and osteoclasts. Communication between these two cell types is essential for maintenance of normal bone homeostasis; however, the mechanisms regulating this cross talk are not completely understood. Many factors that mediate differentiation and function of both osteoblasts and osteoclasts have been identified. The LIM protein Limd1 has been implicated in the regulation of stress osteoclastogenesis through an interaction with the p62/sequestosome protein. Here we show that Limd1 also influences osteoblast progenitor numbers, differentiation, and function. Limd1(-/-) calvarial osteoblasts display increased mineralization and accelerated differentiation. While no significant differences in osteoblast number or function were detected in vivo, bone marrow stromal cells isolated from Limd1(-/-) mice contain significantly more osteoblast progenitors compared to wild type controls when cultured ex vivo. Furthermore, we observed a significant increase in nuclear beta-catenin staining in differentiating Limd1(-/-) calvarial osteoblasts suggesting that Limd1 is a negative regulator of canonical Wnt signaling in osteoblasts. These results demonstrate that Limd1 influences not only stress osteoclastogenesis but also osteoblast function and osteoblast progenitor commitment. Together, these data identify Limd1 as a novel regulator of both bone osetoclast and bone osteoblast development and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657804      PMCID: PMC2570157          DOI: 10.1016/j.yexcr.2008.06.003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  25 in total

1.  The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development.

Authors:  Yunfeng Feng; Haibo Zhao; Hilary F Luderer; Holly Epple; Roberta Faccio; F Patrick Ross; Steven L Teitelbaum; Gregory D Longmore
Journal:  J Biol Chem       Date:  2006-11-08       Impact factor: 5.157

Review 2.  Ex vivo expansion of hematopoietic stem cells and gene therapy development.

Authors:  Rudolf H Zubler
Journal:  Swiss Med Wkly       Date:  2006-12-23       Impact factor: 2.193

3.  Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone.

Authors:  Jean Morissette; Nancy Laurin; Jacques P Brown
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

4.  Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.

Authors:  K Haraguchi; M Ohsugi; Y Abe; K Semba; T Akiyama; T Yamamoto
Journal:  Oncogene       Date:  2007-07-09       Impact factor: 9.867

Review 5.  Wnt signaling and skeletal development.

Authors:  Fei Liu; Sean Kohlmeier; Cun-Yu Wang
Journal:  Cell Signal       Date:  2007-11-28       Impact factor: 4.315

6.  A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3.

Authors:  H Kiss; D Kedra; Y Yang; M Kost-Alimova; C Kiss; K P O'Brien; I Fransson; G Klein; S Imreh; J P Dumanski
Journal:  Hum Genet       Date:  1999-12       Impact factor: 4.132

7.  The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway.

Authors:  L Sanz; M T Diaz-Meco; H Nakano; J Moscat
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

8.  Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.

Authors:  Dorit Naot; Usha Bava; Brya Matthews; Karen E Callon; Gregory D Gamble; Michael Black; Sarah Song; Rocco P Pitto; Tim Cundy; Jill Cornish; Ian R Reid
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

9.  G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow.

Authors:  Craig L Semerad; Matthew J Christopher; Fulu Liu; Brenton Short; Paul J Simmons; Ingrid Winkler; Jean-Pierre Levesque; Jean Chappel; F Patrick Ross; Daniel C Link
Journal:  Blood       Date:  2005-07-21       Impact factor: 22.113

Review 10.  Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.

Authors:  Angela Rogers; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2005-08-16       Impact factor: 5.958

View more
  8 in total

1.  Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.

Authors:  Yanshuai Zhang; Erin Gatenby McNerny; Masahiko Terajima; Mekhala Raghavan; Genevieve Romanowicz; Zhanpeng Zhang; Honghao Zhang; Nobuhiro Kamiya; Margaret Tantillo; Peizhi Zhu; Gregory J Scott; Manas K Ray; Michelle Lynch; Peter X Ma; Michael D Morris; Mitsuo Yamauchi; David H Kohn; Yuji Mishina
Journal:  Bone       Date:  2016-04-23       Impact factor: 4.398

2.  LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death.

Authors:  Ling Wang; Mary E A Howell; Brooke McPeak; Katrina Riggs; Carissa Kohne; Jether Uel Yohanon; Daniel E Foxler; Tyson V Sharp; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  Oncotarget       Date:  2017-12-26

3.  Multi-omics Data Integration for Identifying Osteoporosis Biomarkers and Their Biological Interaction and Causal Mechanisms.

Authors:  Chuan Qiu; Fangtang Yu; Kuanjui Su; Qi Zhao; Lan Zhang; Chao Xu; Wenxing Hu; Zun Wang; Lanjuan Zhao; Qing Tian; Yuping Wang; Hongwen Deng; Hui Shen
Journal:  iScience       Date:  2020-01-17

4.  Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma.

Authors:  Ling Wang; Ayrianna Sparks-Wallace; Jared L Casteel; Mary E A Howell; Shunbin Ning
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 5.738

Review 5.  New Look of EBV LMP1 Signaling Landscape.

Authors:  Ling Wang; Shunbin Ning
Journal:  Cancers (Basel)       Date:  2021-10-29       Impact factor: 6.575

6.  Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes.

Authors:  Kathryn Davidson; Paul Grevitt; Maria F Contreras-Gerenas; Katherine S Bridge; Miguel Hermida; Kunal M Shah; Faraz K Mardakheh; Mark Stubbs; Rosemary Burke; Pedro Casado; Pedro R Cutillas; Sarah A Martin; Tyson V Sharp
Journal:  Cell Death Dis       Date:  2021-11-11       Impact factor: 8.469

7.  Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.

Authors:  Ce Shi; Ayaka Iura; Masahiko Terajima; Fei Liu; Karen Lyons; Haichun Pan; Honghao Zhang; Mitsuo Yamauchi; Yuji Mishina; Hongchen Sun
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

8.  Imputation of canine genotype array data using 365 whole-genome sequences improves power of genome-wide association studies.

Authors:  Jessica J Hayward; Michelle E White; Michael Boyle; Laura M Shannon; Margret L Casal; Marta G Castelhano; Sharon A Center; Vicki N Meyers-Wallen; Kenneth W Simpson; Nathan B Sutter; Rory J Todhunter; Adam R Boyko
Journal:  PLoS Genet       Date:  2019-09-16       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.